| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 01/11/2007 | WO2007003964A1 G-protein coupled receptor agonists |
| 01/11/2007 | CA2613236A1 G-protein coupled receptor agonists |
| 01/10/2007 | EP1741715A1 Epothilone derivatives and their synthesis and use |
| 01/10/2007 | EP1741712A2 Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of Nebivolol |
| 01/10/2007 | CN1894233A Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2h-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them |
| 01/10/2007 | CN1894209A Prostaglandin synthesis |
| 01/09/2007 | US7161014 Gas phase synthesis of methylene lactones using novel grafted catalyst |
| 01/09/2007 | US7160919 C7 lactyloxy-substituted taxanes |
| 01/09/2007 | US7160911 Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals |
| 01/04/2007 | US20070004791 (1 alpha ,5 alpha ,6 alpha )-N-[3-benzyl-3-azabicyclo[3.1.0]hexyl-6-(aminomethyl)-yl]-2-hydroxy-2,2-diphenyl acetamide; high affinity towards Muscarinic 3 receptors; avoiding adverse side effects; for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems |
| 01/03/2007 | EP1737847A2 Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol |
| 01/03/2007 | EP1737444A1 C7 lactyloxy-substituted taxanes |
| 01/03/2007 | CN1890234A Novel quinoline derivatives |
| 01/03/2007 | CN1890224A 6-substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose)polymerase inhibitors |
| 01/03/2007 | CN1293075C Indole and 2,3-indoline derivative, their preparation and application |
| 01/02/2007 | US7157590 Chemical intermediate for vision defect drug |
| 01/02/2007 | US7157489 HIV protease inhibitors |
| 01/02/2007 | US7157486 For therapy and prophylaxis of hepatitis C virus (HCV) infection |
| 01/02/2007 | US7157474 Mixing at least one nonaqueous, pharmaceutically acceptable solvent and a taxane compound |
| 01/02/2007 | US7157454 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2007 | CA2153419C Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 12/28/2006 | WO2006136924A1 Histamine-3 receptor antagonists |
| 12/28/2006 | WO2006136462A1 Benzofuranone derivatives as nonsteroidal progesterone receptor modulators |
| 12/28/2006 | WO2006105222A3 Carboxamide inhibitors of tgfb |
| 12/28/2006 | US20060293527 Analogs of epothilone |
| 12/28/2006 | US20060293306 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 12/28/2006 | CA2611900A1 Benzofuranone derivatives as nonsteroidal progesterone receptor modulators |
| 12/27/2006 | EP1735301A1 Pyridine derivatives as cannabinoid receptor modulators |
| 12/27/2006 | EP1734948A1 Tri-substitued 2-benzhydryl-5-benzlamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6-disubstituted pyran derivatives |
| 12/27/2006 | EP1734942A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| 12/27/2006 | CN1886505A DNA participating in hydroxylation of macrolide compound |
| 12/27/2006 | CN1886393A Modulators of ATP-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 12/27/2006 | CN1884277A Dibenzanthracene, dinaphthopyran and dibenzanthracene, dinaphtho spiropyran analog compound and its preparation |
| 12/27/2006 | CN1291983C Luminescent element material and luminescent element comprising the same |
| 12/26/2006 | US7153981 Combining a lactone of the Formula I with formaldehyde derived from a formaldehyde source and a solvent at a temperature and pressure sufficient to cause the reaction mixture to exist as a supercritical or near-critical fluid |
| 12/26/2006 | US7153968 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease, eosinophilic granuloma, psoriasis and other benign or malignant proliferative skin diseases, endotoxic shock, laminitis in horses, colic in horses, septic shock, ulcerative colitis, Crohn's disease, reperfusion injury |
| 12/26/2006 | US7153885 Stolonoxides |
| 12/26/2006 | US7153884 C-2′ methylated derivatives of paclitaxel for use as antitumour agents |
| 12/21/2006 | WO2006134955A1 1, 2-di(cyclic group)substituted benzene derivative |
| 12/21/2006 | WO2006134163A2 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 12/21/2006 | WO2006133926A1 Pyrazole derivates as cannabinoid receptor modulators |
| 12/21/2006 | WO2005110994A8 Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
| 12/21/2006 | US20060287387 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders |
| 12/21/2006 | US20060287304 Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient |
| 12/21/2006 | CA2611443A1 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 12/21/2006 | CA2607054A1 1, 2-di(cyclic group)substituted benzene derivative |
| 12/20/2006 | EP1732536A2 Triptolide lactone ring derivatives as immunomodulators and anticancer agents |
| 12/20/2006 | EP1263729B1 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 12/20/2006 | CN1882547A 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 12/19/2006 | US7151185 Converting lactones such as gamma-butyrolactone to their alpha-methylene substituted forms using an oxynitride catalyst derived from an aluminum compound, phosphoric acid, optionally a tetraalkoxysilane and ammonia |
| 12/19/2006 | CA2158863C Taxanes having a pyridyl substituted side-chain |
| 12/14/2006 | WO2006133326A1 Inhibitors of hcv replication |
| 12/14/2006 | WO2006131398A2 Inhibitors of soluble adenylate cyclase |
| 12/14/2006 | WO2006131304A2 Process for preparing renin inhibitors |
| 12/14/2006 | WO2006131192A1 New materials for organic electroluminescence devices |
| 12/14/2006 | WO2006113981A3 Process to obtain dibenzylbutyrolactonic, tetrahydrofuranic lignans and their synthetic and semi-synthetic derivatives, their analgesic and anti-inflammatory activities, topical and/or systemic formulations containing said lignans and their respective therapeutic method |
| 12/14/2006 | WO2006110884A8 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists |
| 12/14/2006 | US20060277687 Reacting compounds such as 1, 3-butadiene with at least one peroxide to form bisepoxide in presence of manganese catalyst prepared by reacting manganese acetate with 1,4,7-trimethyl-1,4,7-triazacyclononane and a coligand; for use in producing erythro-dithiol compound |
| 12/14/2006 | CA2608575A1 Process for preparing renin inhibitors |
| 12/14/2006 | CA2606692A1 Inhibitors of soluble adenylate cyclase |
| 12/13/2006 | EP1731148A1 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer |
| 12/13/2006 | EP1730165A1 Inhibitors of hepatitis c virus ns3 protease |
| 12/13/2006 | EP1730140A1 Opioid receptor antagonists |
| 12/13/2006 | EP1729759A1 Salvinorin derivatives and uses thereof |
| 12/12/2006 | US7148242 N-formyl hydroxylamine compounds, compositions and methods of use |
| 12/12/2006 | US7148240 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 12/12/2006 | US7148226 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 12/12/2006 | US7148221 Vanilloid receptor ligands and their use in treatments |
| 12/07/2006 | WO2006128803A1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists |
| 12/07/2006 | US20060276512 Fumagillol derivatives and preparing method thereof |
| 12/07/2006 | CA2608819A1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists |
| 12/06/2006 | EP1727883A2 Vegetable based dioxanone derivatives, synthesis and uses thereof |
| 12/06/2006 | EP1727870A1 Reactive coalescent agents |
| 12/06/2006 | EP1727799A1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products |
| 12/06/2006 | EP1727425A1 Use of epoxides as fungicides |
| 12/06/2006 | CN1875022A Tocopherol-modified therapeutic drug compounds |
| 12/06/2006 | CN1875015A Benzo [b][1,4] dioxepine derivatives |
| 12/06/2006 | CN1288148C 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 12/05/2006 | US7144888 Vanilloid receptor ligands and their use in treatments |
| 12/05/2006 | US7144885 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders |
| 11/30/2006 | WO2006126939A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |
| 11/30/2006 | WO2006125530A1 Tetrahydropyrane derivatives comprising several rings containing oxygen and method for the production thereof |
| 11/30/2006 | WO2006125529A1 Formyltetrahydropyrans, method for the production thereof and use thereof in the production of liquid crystal compounds |
| 11/30/2006 | WO2006125511A1 Pyran/dioxan derivatives and use thereof in liquid crystal media |
| 11/30/2006 | WO2006111858A3 Bis-(coumarin) compounds with anti-inflammatory activity |
| 11/30/2006 | US20060270862 Analogs of discodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof |
| 11/30/2006 | DE102006020181A1 Liquid crystal medium with a nematic phase, useful in electro optical display, comprises a pyran-containing component |
| 11/30/2006 | CA2609747A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphthalene derivatives modulating the 5ht6 receptor |
| 11/29/2006 | EP1726586A1 Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient |
| 11/29/2006 | EP1725529A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain |
| 11/29/2006 | CN1869035A Lactone monomer compound and its application in preparing medicine for treating cancer |
| 11/29/2006 | CN1286828C Process for preparing paclitaxel |
| 11/28/2006 | US7141682 Liquid phase synthesis of methylene lactones using oxnitride catalyst |
| 11/28/2006 | US7141574 Viral polymerase inhibitors |
| 11/28/2006 | CA2155018C C7 taxane derivatives and pharmaceutical compositions containing them |
| 11/23/2006 | WO2006110884A3 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists |
| 11/23/2006 | WO2006071538A3 Substituted biaryl analogues |
| 11/23/2006 | US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 11/23/2006 | US20060264471 3-(cyclopenten-1-yl)-benzyl-or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derviatives and use thereof as medicines for treating schizophrenia |
| 11/23/2006 | US20060264440 Pyrazoles and methods of making and using the same |